Smith & Nephew SNATS Debt to Equity Ratio 2010-2024 | SNN

Current and historical debt to equity ratio values for Smith & Nephew SNATS (SNN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Smith & Nephew SNATS debt/equity for the three months ending December 31, 2024 was 0.62.
Smith & Nephew SNATS Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-12-31 $5.09B $5.27B 0.97
2024-06-30 $5.34B $5.21B 1.03
2023-12-31 $4.77B $5.22B 0.91
2023-06-30 $4.61B $5.23B 0.88
2022-12-31 $4.71B $5.26B 0.90
2022-06-30 $4.71B $5.40B 0.87
2021-12-31 $5.35B $5.57B 0.96
2021-06-30 $5.60B $5.33B 1.05
2020-12-31 $5.73B $5.28B 1.09
2020-06-30 $4.58B $4.96B 0.92
2019-12-31 $4.16B $5.14B 0.81
2019-06-30 $3.99B $4.95B 0.81
2018-12-31 $3.19B $4.87B 0.65
2018-06-30 $3.07B $4.64B 0.66
2017-12-31 $3.22B $4.64B 0.69
2017-06-30 $3.24B $4.20B 0.77
2016-12-31 $3.39B $3.96B 0.86
2015-12-31 $3.20B $3.97B 0.81
2015-06-30 $3.17B $4.05B 0.78
2014-12-31 $3.27B $4.04B 0.81
2014-09-30 $3.63B $4.02B 0.90
2014-06-30 $3.59B $4.16B 0.86
2014-03-31 $1.72B $4.22B 0.41
2013-12-31 $1.77B $4.05B 0.44
2013-09-30 $1.66B $3.91B 0.42
2013-06-30 $1.56B $3.90B 0.40
2013-03-31 $1.51B $3.95B 0.38
2012-12-31 $1.76B $3.88B 0.45
2012-09-30 $1.36B $3.64B 0.37
2012-06-30 $1.26B $3.56B 0.35
2012-03-31 $1.43B $3.45B 0.41
2011-12-31 $1.56B $3.19B 0.49
2011-09-30 $1.76B $3.06B 0.58
2011-06-30 $1.78B $3.13B 0.57
2011-03-31 $1.79B $3.00B 0.60
2010-12-31 $1.96B $2.77B 0.71
2010-09-30 $2.40B $2.48B 0.97
2010-06-30 $2.27B $2.31B 0.98
2010-03-31 $2.31B $2.23B 1.04
2009-12-31 $2.39B $2.18B 1.10
2009-09-30 $2.62B $2.01B 1.30
2009-06-30 $2.64B $1.88B 1.40
2009-03-31 $2.60B $1.71B 1.52
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $13.187B $5.810B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $237.401B 28.55
Boston Scientific (BSX) United States $145.814B 36.50
Stryker (SYK) United States $145.229B 30.37
EssilorLuxottica (ESLOY) France $130.605B 0.00
Medtronic (MDT) Ireland $113.492B 16.09
Lonza Group Ag (LZAGY) Switzerland $51.916B 0.00
Haleon (HLN) United Kingdom $49.556B 28.23
ResMed (RMD) United States $36.981B 27.78
Agilent Technologies (A) United States $33.778B 22.02
GE HealthCare Technologies (GEHC) United States $33.476B 15.89
Terumo (TRUMY) Japan $27.213B 35.35
Koninklijke Philips (PHG) Netherlands $22.201B 15.96
Insulet (PODD) United States $21.367B 83.87
Zimmer Biomet Holdings (ZBH) United States $18.451B 11.85
Baxter (BAX) United States $16.093B 12.02
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Demant (WILYY) Denmark $8.854B 0.00
Bio-Rad Laboratories (BIO) United States $6.325B 22.01
Lantheus Holdings (LNTH) United States $5.545B 13.99
Prestige Consumer Healthcare (PBH) United States $4.207B 18.80
Perrigo (PRGO) Ireland $3.746B 9.49
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.428B 15.61
ICU Medical (ICUI) United States $3.258B 24.02
Envista Holdings (NVST) United States $3.198B 26.58
GN Store Nord (GNNDY) Denmark $2.319B 19.20
QuidelOrtho (QDEL) United States $2.021B 13.90
LeMaitre Vascular (LMAT) United States $1.839B 41.10
AtriCure (ATRC) United States $1.600B 0.00
Acuren (TIC) United States $1.308B 0.00
Neogen (NEOG) United States $1.220B 15.61
AdaptHealth (AHCO) United States $1.187B 12.05
BioLife Solutions (BLFS) United States $1.107B 0.00
Green Thumb Industries (GTBIF) United States $1.061B 23.86
Phibro Animal Health (PAHC) United States $0.993B 12.70
Kestra Medical Technologies (KMTS) United States $0.963B 0.00
InMode (INMD) Israel $0.888B 8.95
CeriBell (CBLL) United States $0.657B 0.00
Evolus (EOLS) United States $0.656B 0.00
Capricor Therapeutics (CAPR) United States $0.637B 0.00
Owens & Minor (OMI) United States $0.616B 5.11
Maravai LifeSciences Holdings (MRVI) United States $0.576B 0.00
Curaleaf Holdings (CURLF) Canada $0.547B 0.00
Valneva SE (VALN) France $0.523B 0.00
Tilray Brands (TLRY) Canada $0.419B 0.00
Surmodics (SRDX) United States $0.416B 0.00
SNDL (SNDL) Canada $0.355B 0.00
VAREX IMAGING (VREX) United States $0.351B 12.92
Aurora Cannabis (ACB) Canada $0.342B 60.90
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Canopy Growth (CGC) Canada $0.281B 0.00
Viemed Healthcare (VMD) United States $0.268B 22.60
Sanuwave Health (SNWV) United States $0.265B 0.00
Cerus (CERS) United States $0.262B 0.00
ZimVie (ZIMV) United States $0.258B 11.75
Sanara MedTech (SMTI) United States $0.255B 0.00
Cresco Labs (CRLBF) United States $0.251B 0.00
Quanterix (QTRX) United States $0.240B 0.00
OraSure Technologies (OSUR) United States $0.219B 0.00
Biote (BTMD) United States $0.216B 6.08
Brainsway (BWAY) Israel $0.216B 57.10
TriSalus Life Sciences (TLSI) United States $0.208B 0.00
Omeros (OMER) United States $0.208B 0.00
Organigram Global (OGI) Canada $0.197B 0.00
High Tide (HITI) Canada $0.189B 0.00
Utah Medical Products (UTMD) United States $0.186B 15.18
Verano Holdings (VRNOF) United States $0.180B 0.00
Exagen (XGN) United States $0.149B 0.00
Vireo Growth (VREOF) United States $0.143B 0.00
FitLife Brands (FTLF) United States $0.134B 16.51
Jin Medical (ZJYL) China $0.109B 0.00
MacroGenics (MGNX) United States $0.098B 0.00
Veru (VERU) United States $0.096B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
Fonar (FONR) United States $0.090B 11.60
Quipt Home Medical (QIPT) United States $0.089B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
Agape ATP (ATPC) $0.077B 0.00
InterCure (INCR) Israel $0.067B 0.00
Cytosorbents (CTSO) United States $0.067B 0.00
Apyx Medical (APYX) United States $0.065B 0.00
Zynex (ZYXI) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.058B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Modular Medical (MODD) United States $0.043B 0.00
Nephros (NEPH) United States $0.043B 57.29
United-Guardian (UG) United States $0.038B 13.02
Rockwell Medical (RMTI) United States $0.033B 0.00
Cellectar Biosciences (CLRB) United States $0.020B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
Safety Shot (SHOT) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.018B 0.00
INLIF (INLF) $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00